Device Trial Radar · NCT03746132
Oxygen for Vascular Incisional Healing
Last checked: Nov 20, 2026Latest source record: Sep 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Mar 7, 2019
Primary completion
Jul 31, 2022
Study completion Jul 31, 2022
Sponsor
- Lead sponsor
- Neogenix, LLC dba OgenixNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of Maryland, College Park
- First posted
- Nov 19, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to evaluate Transdermal Continuous Oxygen Therapy (TCOT) as an adjunct to surgical wound healing in subjects undergoing vascular surgery for lower extremity arterial occlusive disease. It is the intention of this study to administer oxygen using the TCOT approach to the surgical sites of subjects undergoing the surgery and to monitor the healing of the incision as well as infection rate. The hypothesis is that oxygen delivered transdermally to the surgical site in a continuous manner for up to 28 days will accelerate the healing process and reduce the infection rate compared to the Standard of Care.
Conditions
- Surgical Wound Healing
- Lower Extremity
- Revascularization
- Incision
Interventions
EPIFLODevice
EPIFLO is a 3 ounce oxygen generator that continuously delivers 3 ml/hr of pure oxygen to the wound site, to enable tissue regenerative processes, thus driving closure of delayed-healing acute or chronic wounds.
Primary outcomes
What the sponsor says the trial is designed to measure.
- surgical wound closure assessed using modified Bates-Jenson Wound Assessment ToolTime frame: 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Maryland
Baltimore, Maryland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.